These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 26341753

  • 1. Cross reactive molecules of human lymphatic filaria Brugia malayi inhibit Leishmania donovani infection in hamsters.
    Verma R, Joseph SK, Kushwaha V, Kumar V, Siddiqi MI, Vishwakarma P, Shivahare R, Gupta S, Murthy PK.
    Acta Trop; 2015 Dec; 152():103-111. PubMed ID: 26341753
    [Abstract] [Full Text] [Related]

  • 2. Leishmania donovani molecules recognized by sera of filaria infected host facilitate filarial infection.
    Verma R, Kushwaha V, Pandey S, Thota JR, Vishwakarma P, Parmar N, Yadav PK, Tewari P, Kar S, Shukla PK, Murthy PK.
    Parasitol Res; 2018 Sep; 117(9):2901-2912. PubMed ID: 29946763
    [Abstract] [Full Text] [Related]

  • 3. Influence of Brugia malayi life stages and BmAFII fraction on experimental Leishmania donovani infection in hamsters.
    Murthy PK, Dixit S, Gaur RL, Kumar R, Sahoo MK, Shakya N, Joseph SK, Palne S, Gupta S.
    Acta Trop; 2008 May; 106(2):81-9. PubMed ID: 18329620
    [Abstract] [Full Text] [Related]

  • 4. Cross-protective efficacy of immuno-stimulatory recombinant Brugia malayi protein HSP60 against the Leishmania donovani in BALB/c mice.
    Kushwaha V, Kaur S.
    Biologicals; 2021 Jul; 72():18-26. PubMed ID: 34229924
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prophylactic efficacy of high-molecular-weight antigenic fractions of a recent clinical isolate of Leishmania donovani against visceral leishmaniasis.
    Tripathi P, Gupta SK, Sinha S, Sundar S, Dube A, Naik S.
    Scand J Immunol; 2008 Nov; 68(5):492-501. PubMed ID: 18803606
    [Abstract] [Full Text] [Related]

  • 7. Immunization with inflammatory proteome of Brugia malayi adult worm induces a Th1/Th2-immune response and confers protection against the filarial infection.
    Sahoo MK, Sisodia BS, Dixit S, Joseph SK, Gaur RL, Verma SK, Verma AK, Shasany AK, Dowle AA, Murthy PK.
    Vaccine; 2009 Jul 09; 27(32):4263-71. PubMed ID: 19450648
    [Abstract] [Full Text] [Related]

  • 8. Nucleosomal histone proteins of L. donovani: a combination of recombinant H2A, H2B, H3 and H4 proteins were highly immunogenic and offered optimum prophylactic efficacy against Leishmania challenge in hamsters.
    Baharia RK, Tandon R, Sahasrabuddhe AA, Sundar S, Dube A.
    PLoS One; 2014 Jul 09; 9(6):e97911. PubMed ID: 24926878
    [Abstract] [Full Text] [Related]

  • 9. Immunization with the DNA-encoding N-terminal domain of proteophosphoglycan of Leishmania donovani generates Th1-type immunoprotective response against experimental visceral leishmaniasis.
    Samant M, Gupta R, Kumari S, Misra P, Khare P, Kushawaha PK, Sahasrabuddhe AA, Dube A.
    J Immunol; 2009 Jul 01; 183(1):470-9. PubMed ID: 19542458
    [Abstract] [Full Text] [Related]

  • 10. Recombinant NAD-dependent SIR-2 protein of Leishmania donovani: immunobiochemical characterization as a potential vaccine against visceral leishmaniasis.
    Baharia RK, Tandon R, Sharma T, Suthar MK, Das S, Siddiqi MI, Saxena JK, Sundar S, Dube A.
    PLoS Negl Trop Dis; 2015 Mar 01; 9(3):e0003557. PubMed ID: 25745863
    [Abstract] [Full Text] [Related]

  • 11. Immunogenicity and Protective Efficacy of T-Cell Epitopes Derived From Potential Th1 Stimulatory Proteins of Leishmania (Leishmania) donovani.
    Joshi S, Yadav NK, Rawat K, Kumar V, Ali R, Sahasrabuddhe AA, Siddiqi MI, Haq W, Sundar S, Dube A.
    Front Immunol; 2019 Mar 01; 10():288. PubMed ID: 30873164
    [Abstract] [Full Text] [Related]

  • 12. Immunoprotective responses of T helper type 1 stimulatory protein-S-adenosyl-L-homocysteine hydrolase against experimental visceral leishmaniasis.
    Khare P, Jaiswal AK, Tripathi CD, Sundar S, Dube A.
    Clin Exp Immunol; 2016 Aug 01; 185(2):165-79. PubMed ID: 26898994
    [Abstract] [Full Text] [Related]

  • 13. IgG subclass responses to proinflammatory fraction of Brugia malayi in human filariasis.
    Joseph SK, Verma SK, Sahoo MK, Sharma A, Srivastava M, Reddy MV, Murthy PK.
    Indian J Med Res; 2012 May 01; 135(5):650-5. PubMed ID: 22771594
    [Abstract] [Full Text] [Related]

  • 14. Protection against L3 induced Brugia malayi infection in Mastomys coucha pre-immunized with BmAFII fraction of the filarial adult worm.
    Dixit S, Gaur RL, Sahoo MK, Joseph SK, Murthy PS, Murthy PK.
    Vaccine; 2006 Jul 26; 24(31-32):5824-31. PubMed ID: 16757067
    [Abstract] [Full Text] [Related]

  • 15. Immunological consequences of stress-related proteins--cytosolic tryparedoxin peroxidase and chaperonin TCP20--identified in splenic amastigotes of Leishmania donovani as Th1 stimulatory, in experimental visceral leishmaniasis.
    Jaiswal AK, Khare P, Joshi S, Rawat K, Yadav N, Sundar S, Dube A.
    Parasitology; 2015 Apr 26; 142(5):728-44. PubMed ID: 25498563
    [Abstract] [Full Text] [Related]

  • 16. Treatment of Leishmania donovani-infected hamsters with miltefosine: analysis of cytokine mRNA expression by real-time PCR, lymphoproliferation, nitrite production and antibody responses.
    Gupta R, Kushawaha PK, Samant M, Jaiswal AK, Baharia RK, Dube A.
    J Antimicrob Chemother; 2012 Feb 26; 67(2):440-3. PubMed ID: 22121191
    [Abstract] [Full Text] [Related]

  • 17. Troponin 1 of human filarial parasite Brugia malayi: cDNA cloning, expression, purification, and its immunoprophylactic potential.
    Kushwaha V, Tewari P, Mandal P, Tripathi A, Murthy PK.
    Parasitol Res; 2019 Jun 26; 118(6):1849-1863. PubMed ID: 31055672
    [Abstract] [Full Text] [Related]

  • 18. Humoral and cell-mediated immune responses elicited by poly (DL-lactide) adjuvanted filarial antigen molecules.
    Saini V, Verma AK, Kushwaha V, Joseph SK, Murthy PK, Kohli D.
    Drug Deliv; 2014 May 26; 21(3):233-41. PubMed ID: 24171405
    [Abstract] [Full Text] [Related]

  • 19. Th1-stimulatory polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1 kDa offers long-lasting protection against experimental visceral leishmaniasis.
    Kumari S, Samant M, Misra P, Khare P, Sisodia B, Shasany AK, Dube A.
    Vaccine; 2008 Oct 23; 26(45):5700-11. PubMed ID: 18762224
    [Abstract] [Full Text] [Related]

  • 20. Intradermal Immunization of Leishmania donovani Centrin Knock-Out Parasites in Combination with Salivary Protein LJM19 from Sand Fly Vector Induces a Durable Protective Immune Response in Hamsters.
    Fiuza JA, Dey R, Davenport D, Abdeladhim M, Meneses C, Oliveira F, Kamhawi S, Valenzuela JG, Gannavaram S, Nakhasi HL.
    PLoS Negl Trop Dis; 2016 Jan 23; 10(1):e0004322. PubMed ID: 26752686
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.